Oncology Institute (TOI) Competitors $3.05 -0.12 (-3.79%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$3.09 +0.04 (+1.31%) As of 09/12/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TOI vs. FTRE, PNTG, CDNA, CSTL, FLGT, INNV, AGL, AUNA, PSNL, and TALKShould you be buying Oncology Institute stock or one of its competitors? The main competitors of Oncology Institute include Fortrea (FTRE), The Pennant Group (PNTG), CareDx (CDNA), Castle Biosciences (CSTL), Fulgent Genetics (FLGT), InnovAge (INNV), Agilon Health (AGL), Auna (AUNA), Personalis (PSNL), and Talkspace (TALK). These companies are all part of the "healthcare" industry. Oncology Institute vs. Its Competitors Fortrea The Pennant Group CareDx Castle Biosciences Fulgent Genetics InnovAge Agilon Health Auna Personalis Talkspace Oncology Institute (NASDAQ:TOI) and Fortrea (NASDAQ:FTRE) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership, media sentiment and valuation. Do analysts prefer TOI or FTRE? Oncology Institute presently has a consensus target price of $7.00, suggesting a potential upside of 129.51%. Fortrea has a consensus target price of $11.50, suggesting a potential upside of 13.86%. Given Oncology Institute's stronger consensus rating and higher possible upside, equities research analysts plainly believe Oncology Institute is more favorable than Fortrea.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oncology Institute 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33Fortrea 1 Sell rating(s) 9 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.17 Do institutionals & insiders hold more shares of TOI or FTRE? 36.9% of Oncology Institute shares are owned by institutional investors. 8.5% of Oncology Institute shares are owned by insiders. Comparatively, 0.4% of Fortrea shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is TOI or FTRE more profitable? Oncology Institute has a net margin of -14.26% compared to Fortrea's net margin of -37.57%. Fortrea's return on equity of 5.25% beat Oncology Institute's return on equity.Company Net Margins Return on Equity Return on Assets Oncology Institute-14.26% -1,527.21% -34.25% Fortrea -37.57%5.25%1.72% Which has more volatility and risk, TOI or FTRE? Oncology Institute has a beta of 0.1, meaning that its share price is 90% less volatile than the S&P 500. Comparatively, Fortrea has a beta of 1.91, meaning that its share price is 91% more volatile than the S&P 500. Which has better valuation and earnings, TOI or FTRE? Oncology Institute has higher earnings, but lower revenue than Fortrea. Oncology Institute is trading at a lower price-to-earnings ratio than Fortrea, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOncology Institute$393.41M0.72-$64.66M-$0.68-4.49Fortrea$2.73B0.34-$328.50M-$11.38-0.89 Does the media refer more to TOI or FTRE? In the previous week, Fortrea had 18 more articles in the media than Oncology Institute. MarketBeat recorded 21 mentions for Fortrea and 3 mentions for Oncology Institute. Fortrea's average media sentiment score of 0.86 beat Oncology Institute's score of 0.07 indicating that Fortrea is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Oncology Institute 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Fortrea 8 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryOncology Institute beats Fortrea on 9 of the 16 factors compared between the two stocks. Get Oncology Institute News Delivered to You Automatically Sign up to receive the latest news and ratings for TOI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TOI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TOI vs. The Competition Export to ExcelMetricOncology InstituteMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$296.41M$7.66B$5.87B$10.14BDividend YieldN/A2.77%5.68%4.59%P/E Ratio-4.4974.0174.5225.93Price / Sales0.7242.20549.78198.13Price / CashN/A24.1437.5660.44Price / Book61.007.3512.166.29Net Income-$64.66M$238.91M$3.28B$270.77M7 Day Performance-7.58%2.63%0.87%3.88%1 Month Performance-25.61%1.47%4.96%4.88%1 Year Performance826.49%16.57%60.74%26.01% Oncology Institute Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TOIOncology Institute2.6025 of 5 stars$3.05-3.8%$7.00+129.5%+917.0%$296.41M$393.41M-4.49660FTREFortrea3.0467 of 5 stars$10.32-11.3%$12.78+23.8%-51.0%$1.06B$2.70B-0.9115,500News CoverageAnalyst ForecastPNTGThe Pennant Group4.3491 of 5 stars$24.51+0.9%$34.40+40.4%-23.2%$839.51M$695.24M31.427,000CDNACareDx4.303 of 5 stars$13.34-3.5%$27.67+107.4%-54.0%$735.60M$333.79M13.08740Positive NewsAnalyst ForecastCSTLCastle Biosciences2.2379 of 5 stars$24.06+2.1%$37.00+53.8%-30.2%$683.43M$332.07M-68.74540News CoveragePositive NewsAnalyst ForecastFLGTFulgent Genetics4.0788 of 5 stars$22.27+1.5%$25.33+13.8%-0.6%$671.87M$303.22M-13.421,313News CoveragePositive NewsINNVInnovAge0.8871 of 5 stars$4.03+6.3%$5.00+24.1%-24.4%$511.70M$763.85M-17.522,350Trending NewsEarnings ReportAnalyst RevisionAGLAgilon Health2.8748 of 5 stars$1.26+4.6%$3.07+144.7%-67.9%$497.31M$6.06B-1.631,076AUNAAuna3.7505 of 5 stars$6.35-0.2%$10.70+68.5%-17.9%$470.72M$1.17B7.2114,842Negative NewsPSNLPersonalis4.0113 of 5 stars$5.32+1.5%$7.42+39.4%+2.1%$464.67M$84.61M-4.16400News CoverageTALKTalkspace4.1003 of 5 stars$2.67+2.3%$4.50+68.5%+39.1%$437.09M$187.59M133.57500Positive News Related Companies and Tools Related Companies Fortrea Alternatives The Pennant Group Alternatives CareDx Alternatives Castle Biosciences Alternatives Fulgent Genetics Alternatives InnovAge Alternatives Agilon Health Alternatives Auna Alternatives Personalis Alternatives Talkspace Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TOI) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Institute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
